Search
forLearn
5 / 801 resultslearn Bhringraj
learn Shatavari
learn Ashwagandha
learn Brahmi extract
Research
5 / 32 results
research THERAPEUTIC EFFICACY OF RAKTAMOKSHANA AND SHAMANA CHIKITSA IN THE AYURVEDIC MANAGEMENT OF INDRALUPTA (ALOPECIA AREATA): A CASE REPORT
Ayurvedic treatment successfully regrew hair in a 19-year-old with alopecia areata in 2 months.
research A CASE STUDY ON AYURVEDIC MANAGEMENT OF ALOPACIA AREATA- THROUGH EXTERNAL TREATMENT
Ayurvedic treatment led to significant hair regrowth in alopecia areata.
research Effect of Wet Cupping with Rasayana Chikitsa in Management of Alopecia Areata (Indralupt)
Wet cupping and Rasayana Chikitsa may help regrow hair in alopecia areata.
research Parasurgical Management of Indralupta (Alopecia Areata) by Jalaukavcharana (Leech Therapy): A Case Report
Leech therapy effectively treated a young girl's patchy hair loss with minimal complications.
research Clinical Outcome of Ayurvedic Management of Indralupta (Alopecia Areata)- A Case Study
Ayurvedic treatment may help manage alopecia areata.
Community Join
5 / 1000+ resultscommunity Temples after a month
The conversation discusses hair loss treatments, specifically using Minoxidil, finasteride, and RU58841. The focus is on progress observed at the temples after one month of treatment.
community People are hyped about PP405 but what about Veradermics phase 2!
Veradermics' phase 2 trial of slow-release oral minoxidil shows promising hair regrowth with minimized side effects, gaining significant attention and funding. PP405 is also noted for its potential as a side-effect-free alternative.
community 2 month update. Fin+minox+ketoconazole+dermarolling+mk677+zink&d3
A user reports significant hair density increase and new growth at the temples after two months of using finasteride, minoxidil, ketoconazole, dermarolling, MK-677, zinc, and vitamin D3, with shedding stopping a week ago. They recently added MK-677 to their regimen.
community P-1075: a BETTER version of Minoxidil
P-1075 is a more potent hair growth agent than Minoxidil, but it poses significant heart risks, making it unsafe for use. Despite promising results in macaques, concerns about its cardiotoxicity in rats have halted its development.
community Ruxolitinib - Start of a case study
The conversation is about a user trying a new hair loss treatment, Ruxolitinib, alongside their existing regimen of finasteride, minoxidil, ketoconazole shampoo, and microneedling. They plan to apply Ruxolitinib to their temples daily for 1-2 months.